Loading…
Efficacy of myo-inositol and zinc on insulin resistance in a paediatric population with obesity
To assess the efficacy of the combined administration of myo-inositol and zinc, a mineral involved in the insulin pathway, in paediatric obesity with insulin resistance on HOMA-IR, glucose-insulin metabolism, and lipid profile. Double-blind, randomized, placebo-controlled study conducted in North It...
Saved in:
Published in: | Diabetes, obesity & metabolism obesity & metabolism, 2025-01 |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c175t-e8d27d1a39826ae410e75849cddee9255bad7c328dd01c18105891a2a57067163 |
container_end_page | |
container_issue | |
container_start_page | |
container_title | Diabetes, obesity & metabolism |
container_volume | |
creator | Antoniotti, Valentina Partenope, Cristina Solito, Arianna Mancioppi, Valentina Baima, Jessica Medina, Federico Dimarakis, Sotirios Agostini, Alida Sista, Maria T Monzani, Alice Scotti, Lorenza Rabbone, Ivana Prodam, Flavia Bellone, Simonetta |
description | To assess the efficacy of the combined administration of myo-inositol and zinc, a mineral involved in the insulin pathway, in paediatric obesity with insulin resistance on HOMA-IR, glucose-insulin metabolism, and lipid profile.
Double-blind, randomized, placebo-controlled study conducted in North Italy. Fifty-six patients (10-18 years, Tanner stage ≥3) with obesity and insulin resistance were randomized to myo-inositol (2000 mg), zinc gluconate (5 mg), and galactooligosaccharides (GOS) from plant-based origin (1000 mg) (TRT) or placebo (PLC) containing only GOS from plant-based origin (1000 mg). All patients received an isocaloric diet following the Mediterranean diet style. Data were collected at baseline (V0) and after 3 months (V1). The primary outcome was the insulin resistance index (HOMA-IR).
Fifty out of 56 recruited subjects completed the study. TRT improved HDL cholesterol level compared to PLC (p = 0.05) but not insulin resistance. A stratified post hoc analysis was performed by sex, BMI, and subgroups of adherence to the Mediterranean diet. Subjects were divided for obesity grade, fasting insulin (p = 0.0137) and HOMA-IR (p = 0.0273) were lower in TRT than in PLC patients, with a greater effect on severe obesity. No adverse events were detected.
Three months of supplementation with myo-inositol and zinc were beneficial on lipid profile and in managing obesity complications at least in subjects with severe phenotype. Thus, myo-inositol and zinc could be used as non-pharmacological agents. This work suggests a long-term study with a larger sample size to enrich the findings. |
doi_str_mv | 10.1111/dom.16185 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3153914351</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3153914351</sourcerecordid><originalsourceid>FETCH-LOGICAL-c175t-e8d27d1a39826ae410e75849cddee9255bad7c328dd01c18105891a2a57067163</originalsourceid><addsrcrecordid>eNo9kD1PwzAURS0EoqUw8AeQRxhS_Ow4dkZUlQ-pEgvMlms7wiixQ-wIlV9PaIG7vKunozschC6BLGHKrY3dEiqQ_AjNoaxYAYxWx_tOC1kTOkNnKb0TQkomxSmasVpI4BLmSK2bxhttdjg2uNvFwoeYfI4t1sHiLx8MjgH7kMbWBzy45FPWwbjphTXutbNe58Eb3Md-bHX2E_3p8xuO24nNu3N00ug2uYvfu0Cv9-uX1WOxeX54Wt1tCgOC58JJS4UFzWpJK-1KIE5wWdbGWudqyvlWW2EYldYSMCCBcFmDppoLUgmo2AJdH3b7IX6MLmXV-WRc2-rg4pgUA85qKBmHCb05oGaIKQ2uUf3gOz3sFBD141NNPtXe58Re_c6O287Zf_JPIPsGquhwyg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3153914351</pqid></control><display><type>article</type><title>Efficacy of myo-inositol and zinc on insulin resistance in a paediatric population with obesity</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Antoniotti, Valentina ; Partenope, Cristina ; Solito, Arianna ; Mancioppi, Valentina ; Baima, Jessica ; Medina, Federico ; Dimarakis, Sotirios ; Agostini, Alida ; Sista, Maria T ; Monzani, Alice ; Scotti, Lorenza ; Rabbone, Ivana ; Prodam, Flavia ; Bellone, Simonetta</creator><creatorcontrib>Antoniotti, Valentina ; Partenope, Cristina ; Solito, Arianna ; Mancioppi, Valentina ; Baima, Jessica ; Medina, Federico ; Dimarakis, Sotirios ; Agostini, Alida ; Sista, Maria T ; Monzani, Alice ; Scotti, Lorenza ; Rabbone, Ivana ; Prodam, Flavia ; Bellone, Simonetta</creatorcontrib><description>To assess the efficacy of the combined administration of myo-inositol and zinc, a mineral involved in the insulin pathway, in paediatric obesity with insulin resistance on HOMA-IR, glucose-insulin metabolism, and lipid profile.
Double-blind, randomized, placebo-controlled study conducted in North Italy. Fifty-six patients (10-18 years, Tanner stage ≥3) with obesity and insulin resistance were randomized to myo-inositol (2000 mg), zinc gluconate (5 mg), and galactooligosaccharides (GOS) from plant-based origin (1000 mg) (TRT) or placebo (PLC) containing only GOS from plant-based origin (1000 mg). All patients received an isocaloric diet following the Mediterranean diet style. Data were collected at baseline (V0) and after 3 months (V1). The primary outcome was the insulin resistance index (HOMA-IR).
Fifty out of 56 recruited subjects completed the study. TRT improved HDL cholesterol level compared to PLC (p = 0.05) but not insulin resistance. A stratified post hoc analysis was performed by sex, BMI, and subgroups of adherence to the Mediterranean diet. Subjects were divided for obesity grade, fasting insulin (p = 0.0137) and HOMA-IR (p = 0.0273) were lower in TRT than in PLC patients, with a greater effect on severe obesity. No adverse events were detected.
Three months of supplementation with myo-inositol and zinc were beneficial on lipid profile and in managing obesity complications at least in subjects with severe phenotype. Thus, myo-inositol and zinc could be used as non-pharmacological agents. This work suggests a long-term study with a larger sample size to enrich the findings.</description><identifier>ISSN: 1462-8902</identifier><identifier>ISSN: 1463-1326</identifier><identifier>EISSN: 1463-1326</identifier><identifier>DOI: 10.1111/dom.16185</identifier><identifier>PMID: 39781581</identifier><language>eng</language><publisher>England</publisher><ispartof>Diabetes, obesity & metabolism, 2025-01</ispartof><rights>2025 John Wiley & Sons Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c175t-e8d27d1a39826ae410e75849cddee9255bad7c328dd01c18105891a2a57067163</cites><orcidid>0000-0003-4173-146X ; 0000-0001-9660-5335</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39781581$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Antoniotti, Valentina</creatorcontrib><creatorcontrib>Partenope, Cristina</creatorcontrib><creatorcontrib>Solito, Arianna</creatorcontrib><creatorcontrib>Mancioppi, Valentina</creatorcontrib><creatorcontrib>Baima, Jessica</creatorcontrib><creatorcontrib>Medina, Federico</creatorcontrib><creatorcontrib>Dimarakis, Sotirios</creatorcontrib><creatorcontrib>Agostini, Alida</creatorcontrib><creatorcontrib>Sista, Maria T</creatorcontrib><creatorcontrib>Monzani, Alice</creatorcontrib><creatorcontrib>Scotti, Lorenza</creatorcontrib><creatorcontrib>Rabbone, Ivana</creatorcontrib><creatorcontrib>Prodam, Flavia</creatorcontrib><creatorcontrib>Bellone, Simonetta</creatorcontrib><title>Efficacy of myo-inositol and zinc on insulin resistance in a paediatric population with obesity</title><title>Diabetes, obesity & metabolism</title><addtitle>Diabetes Obes Metab</addtitle><description>To assess the efficacy of the combined administration of myo-inositol and zinc, a mineral involved in the insulin pathway, in paediatric obesity with insulin resistance on HOMA-IR, glucose-insulin metabolism, and lipid profile.
Double-blind, randomized, placebo-controlled study conducted in North Italy. Fifty-six patients (10-18 years, Tanner stage ≥3) with obesity and insulin resistance were randomized to myo-inositol (2000 mg), zinc gluconate (5 mg), and galactooligosaccharides (GOS) from plant-based origin (1000 mg) (TRT) or placebo (PLC) containing only GOS from plant-based origin (1000 mg). All patients received an isocaloric diet following the Mediterranean diet style. Data were collected at baseline (V0) and after 3 months (V1). The primary outcome was the insulin resistance index (HOMA-IR).
Fifty out of 56 recruited subjects completed the study. TRT improved HDL cholesterol level compared to PLC (p = 0.05) but not insulin resistance. A stratified post hoc analysis was performed by sex, BMI, and subgroups of adherence to the Mediterranean diet. Subjects were divided for obesity grade, fasting insulin (p = 0.0137) and HOMA-IR (p = 0.0273) were lower in TRT than in PLC patients, with a greater effect on severe obesity. No adverse events were detected.
Three months of supplementation with myo-inositol and zinc were beneficial on lipid profile and in managing obesity complications at least in subjects with severe phenotype. Thus, myo-inositol and zinc could be used as non-pharmacological agents. This work suggests a long-term study with a larger sample size to enrich the findings.</description><issn>1462-8902</issn><issn>1463-1326</issn><issn>1463-1326</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><recordid>eNo9kD1PwzAURS0EoqUw8AeQRxhS_Ow4dkZUlQ-pEgvMlms7wiixQ-wIlV9PaIG7vKunozschC6BLGHKrY3dEiqQ_AjNoaxYAYxWx_tOC1kTOkNnKb0TQkomxSmasVpI4BLmSK2bxhttdjg2uNvFwoeYfI4t1sHiLx8MjgH7kMbWBzy45FPWwbjphTXutbNe58Eb3Md-bHX2E_3p8xuO24nNu3N00ug2uYvfu0Cv9-uX1WOxeX54Wt1tCgOC58JJS4UFzWpJK-1KIE5wWdbGWudqyvlWW2EYldYSMCCBcFmDppoLUgmo2AJdH3b7IX6MLmXV-WRc2-rg4pgUA85qKBmHCb05oGaIKQ2uUf3gOz3sFBD141NNPtXe58Re_c6O287Zf_JPIPsGquhwyg</recordid><startdate>20250109</startdate><enddate>20250109</enddate><creator>Antoniotti, Valentina</creator><creator>Partenope, Cristina</creator><creator>Solito, Arianna</creator><creator>Mancioppi, Valentina</creator><creator>Baima, Jessica</creator><creator>Medina, Federico</creator><creator>Dimarakis, Sotirios</creator><creator>Agostini, Alida</creator><creator>Sista, Maria T</creator><creator>Monzani, Alice</creator><creator>Scotti, Lorenza</creator><creator>Rabbone, Ivana</creator><creator>Prodam, Flavia</creator><creator>Bellone, Simonetta</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4173-146X</orcidid><orcidid>https://orcid.org/0000-0001-9660-5335</orcidid></search><sort><creationdate>20250109</creationdate><title>Efficacy of myo-inositol and zinc on insulin resistance in a paediatric population with obesity</title><author>Antoniotti, Valentina ; Partenope, Cristina ; Solito, Arianna ; Mancioppi, Valentina ; Baima, Jessica ; Medina, Federico ; Dimarakis, Sotirios ; Agostini, Alida ; Sista, Maria T ; Monzani, Alice ; Scotti, Lorenza ; Rabbone, Ivana ; Prodam, Flavia ; Bellone, Simonetta</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c175t-e8d27d1a39826ae410e75849cddee9255bad7c328dd01c18105891a2a57067163</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Antoniotti, Valentina</creatorcontrib><creatorcontrib>Partenope, Cristina</creatorcontrib><creatorcontrib>Solito, Arianna</creatorcontrib><creatorcontrib>Mancioppi, Valentina</creatorcontrib><creatorcontrib>Baima, Jessica</creatorcontrib><creatorcontrib>Medina, Federico</creatorcontrib><creatorcontrib>Dimarakis, Sotirios</creatorcontrib><creatorcontrib>Agostini, Alida</creatorcontrib><creatorcontrib>Sista, Maria T</creatorcontrib><creatorcontrib>Monzani, Alice</creatorcontrib><creatorcontrib>Scotti, Lorenza</creatorcontrib><creatorcontrib>Rabbone, Ivana</creatorcontrib><creatorcontrib>Prodam, Flavia</creatorcontrib><creatorcontrib>Bellone, Simonetta</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes, obesity & metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Antoniotti, Valentina</au><au>Partenope, Cristina</au><au>Solito, Arianna</au><au>Mancioppi, Valentina</au><au>Baima, Jessica</au><au>Medina, Federico</au><au>Dimarakis, Sotirios</au><au>Agostini, Alida</au><au>Sista, Maria T</au><au>Monzani, Alice</au><au>Scotti, Lorenza</au><au>Rabbone, Ivana</au><au>Prodam, Flavia</au><au>Bellone, Simonetta</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy of myo-inositol and zinc on insulin resistance in a paediatric population with obesity</atitle><jtitle>Diabetes, obesity & metabolism</jtitle><addtitle>Diabetes Obes Metab</addtitle><date>2025-01-09</date><risdate>2025</risdate><issn>1462-8902</issn><issn>1463-1326</issn><eissn>1463-1326</eissn><abstract>To assess the efficacy of the combined administration of myo-inositol and zinc, a mineral involved in the insulin pathway, in paediatric obesity with insulin resistance on HOMA-IR, glucose-insulin metabolism, and lipid profile.
Double-blind, randomized, placebo-controlled study conducted in North Italy. Fifty-six patients (10-18 years, Tanner stage ≥3) with obesity and insulin resistance were randomized to myo-inositol (2000 mg), zinc gluconate (5 mg), and galactooligosaccharides (GOS) from plant-based origin (1000 mg) (TRT) or placebo (PLC) containing only GOS from plant-based origin (1000 mg). All patients received an isocaloric diet following the Mediterranean diet style. Data were collected at baseline (V0) and after 3 months (V1). The primary outcome was the insulin resistance index (HOMA-IR).
Fifty out of 56 recruited subjects completed the study. TRT improved HDL cholesterol level compared to PLC (p = 0.05) but not insulin resistance. A stratified post hoc analysis was performed by sex, BMI, and subgroups of adherence to the Mediterranean diet. Subjects were divided for obesity grade, fasting insulin (p = 0.0137) and HOMA-IR (p = 0.0273) were lower in TRT than in PLC patients, with a greater effect on severe obesity. No adverse events were detected.
Three months of supplementation with myo-inositol and zinc were beneficial on lipid profile and in managing obesity complications at least in subjects with severe phenotype. Thus, myo-inositol and zinc could be used as non-pharmacological agents. This work suggests a long-term study with a larger sample size to enrich the findings.</abstract><cop>England</cop><pmid>39781581</pmid><doi>10.1111/dom.16185</doi><orcidid>https://orcid.org/0000-0003-4173-146X</orcidid><orcidid>https://orcid.org/0000-0001-9660-5335</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1462-8902 |
ispartof | Diabetes, obesity & metabolism, 2025-01 |
issn | 1462-8902 1463-1326 1463-1326 |
language | eng |
recordid | cdi_proquest_miscellaneous_3153914351 |
source | Wiley-Blackwell Read & Publish Collection |
title | Efficacy of myo-inositol and zinc on insulin resistance in a paediatric population with obesity |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T02%3A56%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20of%20myo-inositol%20and%20zinc%20on%20insulin%20resistance%20in%20a%20paediatric%20population%20with%20obesity&rft.jtitle=Diabetes,%20obesity%20&%20metabolism&rft.au=Antoniotti,%20Valentina&rft.date=2025-01-09&rft.issn=1462-8902&rft.eissn=1463-1326&rft_id=info:doi/10.1111/dom.16185&rft_dat=%3Cproquest_cross%3E3153914351%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c175t-e8d27d1a39826ae410e75849cddee9255bad7c328dd01c18105891a2a57067163%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3153914351&rft_id=info:pmid/39781581&rfr_iscdi=true |